A study by HZI scientists suggests that probiotic E. coli could be used as a therapeutic agent against cancer
Several bacterial species have pledged promise in fighting tumors. However, most of them are pathogens. In order to use them as a weapon against cancer and other diseases in humans, researchers must find a balance between their therapeutic aggressiveness and safety for the patient.
To overcome this problem, researchers at the Helmholtz Centre for Infection Research (HZI) have shifted their focus from pathogenic bacteria to those with a proven safety profile, namely probiotic E. coli.
First tests in mice indicate that the probiotic bacteria were indeed efficiently targeting the tumors without generating a toxic effect. The research has been published in the journal “Oncotarget” and opens the door to a new approach in fighting cancer.
Cancers are among the leading causes of morbidity and mortality worldwide. Despite improving treatments such as chemotherapy the disease is still advancing. According to statistics of the World Health Organisation from 2012 (WHO) the number of new cases is expected to rise by about 70 percent over the next two decades. Thus, there is an urgent need for new therapeutic approaches. One possibility is to use pathogenic bacteria such as Salmonella.
‘However, there is one big problem when applying them to human patients’, says Dr Dino Kocijancic, scientist in the department of “Molecular Immunology” at the HZI. ‘We have to modify the bacteria in a way that they do not cause harm. The first clinical trials showed that this is possible but hardly without limiting the therapeutic effects’. In this particular case, the attenuation for safety was too extensive so that the therapeutic power was lost.
To solve this problem the scientists tried an opposing strategy by using probiotic bacteria, which are beneficial rather than harmful to the human host. Kocijancic and his colleagues chose E. coli probiotics which are used by millions of people to treat intestinal disorders. Furthermore, those bacterial strains are already well-studied making it easy to give them new properties and functions.
When testing their approach in tumor bearing mice the researchers found that the E. coli probiotics, notably Symbioflor-2, were very efficient in targeting tumors.
‘This indicates that they are holding a great potential in solid tumor therapy even though their therapeutic potency might be slightly lower than that of Salmonella’, says Kocijancic. ‘However, their superior tumor specificity and the fact that they do not need to be weakened will allow us to use them as bio-vehicles delivering therapeutic molecules into tumors’.
The research indicates that a probiotic therapeutic strain more readily tolerated by an immune compromised cancer patient may allow for systemic application and higher dosing compared to the vastly explored attenuated Salmonella. ’We are sure that this will prove correct in further tests. Thus, our new approach will more readily utilize the advantages of bacteria mediated tumor therapy’, says Dr Siegfried Weiss, head of the research group.
Therapy of solid tumors using probiotic Symbioflor-2 – restraints and potential. Dino Kocijancic, Sebastian Felgner, Michael Frahm, Ronja-Melinda Komoll, Aida Iljazovic, Vinay Pawar, Manfred Rohde, Ulrike Heise, Kurt Zimmermann, Florian Gunzer, Juliane Hammer, Katja Crull, Sara Leschner, Siegfried Weiss. Oncotarget; 2016 Mar 10. DOI: 10.18632/oncotarget.8027.
Susanne Thiele | Helmholtz-Zentrum für Infektionsforschung
Generation of a Stable Biradical
22.03.2018 | Julius-Maximilians-Universität Würzburg
Make way for the mini flying machines
21.03.2018 | American Chemical Society
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
21.03.2018 | Physics and Astronomy
21.03.2018 | Materials Sciences
21.03.2018 | Life Sciences